CDK4/6 Inhibitors and Arthralgia: A Single Institution Experience
Article 2021 en
Authors
ΑA
Αngeliki Andrikopoulou
OF
Oraianthi Fiste
KA
Kleoniki Apostolidou
Abstract
1 min read
Though our data reflect a small sample size, we report a reduced arthralgia rate (6.4%) during treatment with CDK4/6 inhibitors compared with that reported in studies of AIs (20-47%).
Shatha AbuHammad, Carleen Cullinane, Claire Martin, Zoe Bacolas, Teresa Ward, Huiqin Chen, Alison Slater, Kerry Ardley, Laura Kirby, Keefe T. Chan, Natalie Brajanovski, Lorey Smith, Aparna D. Rao, Emily J. Lelliott, Margarete Kleinschmidt, Ismael A. Vergara, Anthony T. Papenfuss, Peter K. H. Lau, Prerana Ghosh, Sue Haupt, Ygal Haupt, Elaine Sanij, Gretchen Poortinga, Richard B. Pearson,
Discussion(0)
No comments yet. Be the first to comment.